| Effects of thyroid dysfunction on lipid profile CV Rizos, MS Elisaf, EN Liberopoulos The open cardiovascular medicine journal 5, 76, 2011 | 540 | 2011 |
| Diabetes mellitus and electrolyte disorders G Liamis, E Liberopoulos, F Barkas, M Elisaf World Journal of Clinical Cases: WJCC 2 (10), 488, 2014 | 458 | 2014 |
| Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? SG Tsouli, EN Liberopoulos, DP Mikhailidis, VG Athyros, MS Elisaf Metabolism 55 (10), 1293-1301, 2006 | 382 | 2006 |
| Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study VG Athyros, DP Mikhailidis, TP Didangelos, OI Giouleme, ... Current medical research and opinion 22 (5), 873-883, 2006 | 335 | 2006 |
| “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ... Current vascular pharmacology 9 (5), 533-571, 2011 | 326 | 2011 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 291 | 2017 |
| Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a … VG Athyros, DP Mikhailidis, EN Liberopoulos, AI Kakafika, A Karagiannis, ... Nephrology Dialysis Transplantation 22 (1), 118-127, 2007 | 288 | 2007 |
| Multiple actions of high-density lipoprotein M Florentin, EN Liberopoulos, AS Wierzbicki, DP Mikhailidis Current opinion in cardiology 23 (4), 370-378, 2008 | 281 | 2008 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 258 | 2019 |
| Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease … VG Athyros, EN Liberopoulos, DP Mikhailidis, AA Papageorgiou, ... Angiology 58 (6), 689-697, 2007 | 215 | 2007 |
| Familial hypercholesterolaemia: a global call to arms AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ... Atherosclerosis 243 (1), 257-259, 2015 | 205 | 2015 |
| How safe is the use of thiazolidinediones in clinical practice? CV Rizos, M Elisaf, DP Mikhailidis, EN Liberopoulos Expert opinion on drug safety 8 (1), 15-32, 2009 | 205 | 2009 |
| Diagnosis and management of the metabolic syndrome in obesity EN Liberopoulos, DP Mikhailidis, MS Elisaf Obesity reviews 6 (4), 283-296, 2005 | 198 | 2005 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 194 | 2019 |
| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 193 | 2018 |
| Novel roles of vitamin D in disease: what is new in 2011? S Makariou, EN Liberopoulos, M Elisaf, A Challa European journal of internal medicine 22 (4), 355-362, 2011 | 193 | 2011 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 179 | 2021 |
| Dyslipidemia in patients with thyroid disorders EN Liberopoulos, MS Elisaf HORMONES-ATHENS- 1, 218-223, 2002 | 168 | 2002 |
| Statin-associated adverse effects beyond muscle and liver toxicity DN Kiortsis, TD Filippatos, DP Mikhailidis, MS Elisaf, EN Liberopoulos Atherosclerosis 195 (1), 7-16, 2007 | 165 | 2007 |
| A review of the metabolic effects of sibutramine TD Filippatos, DN Kiortsis, EN Liberopoulos, DP Mikhailidis, MS Elisaf Current medical research and opinion 21 (3), 457-466, 2005 | 147 | 2005 |
